Home>Topics>>Amarin ([[AMRN]] +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application ...
Amarin ([[AMRN]] +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application ...
Amarin ( AMRN +0.3% ) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application is a continuation of its earlier patent, and broadens its claims by guaging the drugs effects against a ...
Read the rest of this article on SeekingAlpha.com: SA Currents